JPRN-jRCTs042210090招募中2 期
A Multicenter Randomized Phase II trial Investigating The Effect of Polyglycolic Acid Sheet for Prevention of Pancreatic Fistula After Gastrectomy with Prophylactic Lymph Node Dissection
Kodera Yasuhiro0 个研究点目标入组 320 人开始时间: 2021年10月28日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 320
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients who were planned to undergo curative gastrectomy with D1+ or more lymp node dissection.
- •Aged 20 years or mroe at the time of registration and written informed consent.
排除标准
- •History of gastrectomy.
- •History of pancreatectomy.
- •Active infection in abdominal cavity.
- •Tumor invasion to pancreas.
- •Patients who were planned pancreatectomy.
- •Patients who were planned splenectomy.
- •Emergency surgery.
- •Patients who were suspected to have allergy to polyglycolic acid.
- •Patients who were planned robotic assisted gastrectomy.
- •Ineligible for the study at the physician's assessment.
研究者
相似试验
招募中
2 期
A multicenter randomized phase II trial evaluating the efficacy and safety of intrapericardial left superior pulmonary vein ligation or division for prevention of thrombosis in the stumpmalignant tumor of the lungJPRN-UMIN000036037iigata Chest Surgery Study Group60
已完成
2 期
Prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients > 60 years with acute myeloid leukemia who are ineligible for induction chemotherapyC92.9Myeloid leukaemia, unspecifiedDRKS00000733niversitätsklinikum Freiburg204
进行中（未招募）
1 期
Clinical trial of low-dose decitabine (DAC) administered alone or in combination with the valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients > 60 years with acute myeloid leukemia who are ineligible for standard chemotherapyEUCTR2009-009916-33-DEniversity Medical Center Freiburg200
尚未招募
2 期
A Phase 2, Multicenter, Randomized Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ST-617 for the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for Head and Neck CancerOral MucositisHead and Neck CancerCancer - Head and neckOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12620000540910PSI CRO Australia Pty. Ltd.110
进行中（未招募）
1 期
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic TherapyEUCTR2024-000203-67-Outside-EU/EEAKadmon Corporation, LLC